UNSPSC 51271604: Butanilicaine

This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7X3WV51F4N. European Medicines Agency schedules Butanilicaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06003MIG. Butanilicaine generally arises in the molecular formula C13H19CLN2O.

UNSPSC 51271604 Butanilicaine, a Commodity code, maps to a narrow pharmaceutical ingredient with minimal recent state and local procurement activity. The code designates a specific local anesthetic compound used in pharmaceutical formulations, but state and local solicitations rarely specify this ingredient by name or individual chemical identifier. When procurement offices source local anesthetics or pharmaceutical compounds, they typically issue RFQs or ITBs at the finished-product or therapeutic-class level rather than at the active-ingredient tier, making activity under this Commodity code difficult to track through public notice channels.

The source does not contain recent state and local contract opportunities tagged to this code. No issuing body, solicitation type, response date, or geographic concentration can be inferred from available records. This code appears to function primarily in federal pharmaceutical contracting and pharmaceutical ingredient supply chains rather than in the state and local procurement ecosystem that issues RFPs, RFQs, and ITBs for goods and services.